Francis Jacob

[Rachel Hevey @DrRachelHevey]

📢 Exciting #PhD Opportunity in Carbohydrate Chemistry!

Join our team @UniBasel to drive developments in glycan-based therapies 💊

🗓️Feb 2025 📍Switzerland 💼4-year funded
🔗Link below
#GlycoTime #AcademicJobs @euroglyco @ozglyco @glyconet_nce @acs_carb @EuChemS @Glyco_Alps

[Department of Biomedicine @DepBiomedicine]

Exciting news! The 7th issue of our DBM newsletter is here! We hope you enjoy reading it! 👇🏼👇🏼👇🏼
https://t.co/ItTWD0iADO

#Newsletter #DBMBasel #departmentofbiomedicine #science #research #biomedicine

[bioRxiv Cancer Bio @biorxiv_cancer]

SMAC mimetics overcome apoptotic resistance in ovarian cancer through MSLN-TNF alpha axis https://t.co/NjvsTliAZu #biorxiv_cancer

[Francis Jacob @labfranz]

@ArthurDondi Super exciting collaboration with many new ideas generated.

[Arthur Dondi @ArthurDondi]

Delighted to present our full-length scRNA-seq study on ovarian cancer patients, in collaboration with the University Hospital Basel @labfranz ! https://t.co/I7LnLDd2gr

Can we simultaneously detect isoform-level gene expression, mutations and gene fusions in cancer cells? 1/

[Francis Jacob @labfranz]

Exciting time! Long-read scRNAseq unveils novel insights into ovarian cancer metastasis. We detected 52,000+ previously unreported isoforms, identified cell-specific changes, gene fusions, & confirmed mutations. https://t.co/J6NYhe3s94 #Genomics #ovariancancer

[Francis Jacob @labfranz]

@CzerwinsMarcin @ElisaTelisa @IainWil92988866 Great conference, science and people. Thx to everyone

[Clémentine Le Magnen @ClemLeMagnen]

Do not forget the deadline for #ESUR23 🔔! Looking forward to receiving your #UrologicalResearch abstracts and to welcoming you in Basel 🧫 🧬🔬

[Clémentine Le Magnen @ClemLeMagnen]

Pleased to share our review discussing the future of #prostatecancer patient-derived #xenografts published in @NatRevUrol . Great effort tackling this topic from Mitchell Lawrence, @ReneaTaylor1, and Gail Risbridger:
https://t.co/lP4Cg1xdeh

[Rachel Hevey @DrRachelHevey]

One week left to submit an application for our open 🌟 glycochemistry postdoc 🌟 positions!

Interested candidates can apply via the UniBasel job portal link in the thread below

#GlycoTime @euroglyco @InnoglyA @acs_carb @Glyco_Alps @glyconet_nce @GFRGlyco @glyco_pm @theNCFG

[bioRxiv @biorxivpreprint]

Detection of isoforms and genomic alterations by high-throughput full-length single-cell RNA sequencing for personalized oncology https://t.co/g7ZPnXN34v #bioRxiv

[Rachel Hevey @DrRachelHevey]

Join our team!!

Xmas came early in the form of a grant 😁

We are looking to fill TWO postdoc positions in chemoenzymatic and/or carbohydrate synthesis, with a focus on developing new glycan-based antimicrobial therapies.

#GlycoTime #ChemPostdoc

More info in thread 👇👇👇

[University of Basel @UniBasel_en]

Cancer cells use sugar molecules on their surface to disable attacks by the body’s immune system. Researchers at the University of Basel now report on how this mechanism can be neutralized.
@LImmunotherapy @DepBiomedicine @UniSpitalBasel
https://t.co/f6GK3imn1Y

[Francis Jacob @labfranz]

@DrRachelHevey @ElisaTelisa @euroglyco Let’s get in touch!

[Alfred Zippelius @AlfredZippelius]

Making glycosylation "hot" for cancer immunotherapy: wonderful collaboration with Heinz Läubli @LImmunotherapy at @DepBiomedicine and @UniSpitalBasel
https://t.co/HHvHambT5H
Much appreciated, thanks !

[Francis Jacob @labfranz]

CRISPR-Cas9 approach for assessing genes predicting PARP inhibition published in @cddpress, https://t.co/h47mqw4Ddi Great team effort! Special thanks to @RicardoBouca, @DepBiomedicine and @UniSpitalBasel

[Heinz Läubli @LImmunotherapy]

Recent review together with Daniel Maslyar and Sam Nalle on Siglecs and sialic acids as target for cancer immunotherapy #glycotime #Immunotherapy

Targeting the Siglec–Sialic Acid Immune Axis in Cancer: Current and Future Approaches https://t.co/NVnFchMryp

[Heinz Läubli @LImmunotherapy]

If you are a scientist interested in glycobiology and cancer immunotherapy, please apply!

https://t.co/l6C30xXWZZ

[Niels Reichardt @nreichardt]

Registration now open for Glycobasque 5
18-19 November 2022, San Sebastian, Spain
keynotes:
Henrik Clausen, DK
Geert-Jan Boons, NL, USA
M.G. Finn, USA
Sabine Flitsch, UK
details: https://t.co/FHW79Cf0vT